e-learning
resources
ERS Research Seminars
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of altered immune response in CF and implication for antiinflammatory therapies
H. Grasemann (Toronto, On, Canada)
Source:
Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Number:
15
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Grasemann (Toronto, On, Canada). Role of altered immune response in CF and implication for antiinflammatory therapies. Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
Oral presentation: Targeting of microRNAs can restore innate anti-viral response in asthma
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014
Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009
Role of pharmacogenomics in host response to treatment
Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease
Year: 2004
Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation
Source: Eur Respir J, 54 (1) 1802390; 10.1183/13993003.02390-2018
Year: 2019
ICS/LABA effects on antiviral innate immune response. An in vitro analysis.
Source: International Congress 2019 – Novel targets and mechanisms in asthma
Year: 2019
Latent TGF-ß binding protein 4 is an important factor that influences anti-inflammatory and cell-protective responses in the pathogenesis of pulmonary emphysema
Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease
Year: 2020
Novel pharmacological inhibition of EZH2 attenuates septic shock by altering innate inflammatory responses to sepsis
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019
The future of targeted therapies for sarcoidosis
Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis
Year: 2005
Mechanism of long-lasting suppression against Th2 immune response in the lung by a novel antedrug TLR7 agonist
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Inflammatory phenotypes of asthma determine effect of inhaled corticosteroids on anti-viral immunity
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020
Activation of proteolytic mechanisms in response to inflammatory stimuli: a possible role in the development of the aleolocapillary barrier damage
Source: Eur Respir J 2003; 22: Suppl. 45, 458s
Year: 2003
Disease-specific inflammatory environments induce different anti-inflammatory MSC actions that play critical roles in mitigating lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019
Polymorphisms of innate immune response genes and severe systemic inflammatory response syndromes
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006
T-cell susceptibility to glucocorticoid (GC)-induced apoptosis: the role in asthma pathogenesis and therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 227s
Year: 2006
Immunotherapy improves inflammatory cytokines, humoral immunity and cellular immunity in septic patients
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010
Immunology and defence mechanism of the developing lung
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept